Nanoparticles provoke immune response against tumors but avoid side effects: In a new study, immunostimulatory drugs slowed tumor growth without producing systemic inflammation

Researchers find that when immunostimulatory drugs called imidazoquinolines are delivered using specialized bottlebrush nanoparticles, the drugs provoke the immune system to attack tumors while eliminating the side effects that occur when the drugs are given on their own.